CYRIB and cancer: In addition, FAM49B knockdown had a significant inhibitory effect on several key cancer pathways, such as TWEAK, PPAR, and Toll-like receptor signaling pathways (Fig. 5D), indicating that FAM49B can regulate the malignant phenotype of BC.